Vera Bril

26.4k total citations · 5 hit papers
386 papers, 15.7k citations indexed

About

Vera Bril is a scholar working on Neurology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vera Bril has authored 386 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Neurology, 94 papers in Physiology and 74 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vera Bril's work include Myasthenia Gravis and Thymoma (133 papers), Peripheral Neuropathies and Disorders (119 papers) and Botulinum Toxin and Related Neurological Disorders (89 papers). Vera Bril is often cited by papers focused on Myasthenia Gravis and Thymoma (133 papers), Peripheral Neuropathies and Disorders (119 papers) and Botulinum Toxin and Related Neurological Disorders (89 papers). Vera Bril collaborates with scholars based in Canada, United States and Germany. Vera Bril's co-authors include Bruce A. Perkins, Eva L. Feldman, Rayaz A. Malik, Andrew J.M. Boulton, Dan Ziegler, Roy Freeman, Jay M. Sosenko, Rodica Pop‐Busui, Carolina Barnett and Hans Katzberg and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Vera Bril

370 papers receiving 15.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetic Neuropathy: A Position Statement by the American Diabetes Association

2016 1.6k citations Eva L. Feldman, Vera Bril et al. profile →
Diabetic Neuropathies

2005 1.4k citations Vera Bril, Eva L. Feldman et al. profile →
Diabetic neuropathy

2019 978 citations Eva L. Feldman, Douglas W. Zochodne et al. profile →
Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]

2011 449 citations Vera Bril, J. England et al. Neurology profile →
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

2024 36 citations Vera Bril, Tuan Vu et al. profile →

Peers

Countries citing papers authored by Vera Bril

Since Specialization

Citations

This map shows the geographic impact of Vera Bril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Bril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Bril more than expected).

Fields of papers citing papers by Vera Bril

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Bril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Bril. The network helps show where Vera Bril may publish in the future.

Co-authorship network of co-authors of Vera Bril

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Bril. A scholar is included among the top collaborators of Vera Bril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Bril. Vera Bril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P.053 Concomitant corticosteroid use in ravulizumab-treated adults with anti-AChR antibody-positive gMG: results from the CHAMPION MG open-label extension 2024 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·(unknown), Djillali Annane, Andreas Meisel, (unknown), (unknown), Masahisa Katsuno, Vera Bril, Rasha Aguzzi, Glen Frick, (unknown)	1
2	Aging and infectious diseases in myasthenia gravis 2024 ·Journal of the Neurological Sciences ·Vera Bril, (unknown)	1
3	Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors 2024 ·JTO Clinical and Research Reports ·(unknown), (unknown), Hans Katzberg, Vera Bril, (unknown), Warren Mason, (unknown), Aideen E. Ryan, David W. Hogg, Srikala S. Sridhar, Neesha C. Dhani, Anna Spreafico, Lawson Eng, Adrian G. Sacher, Penelope A. Bradbury, Geoffrey Liu, Natasha B. Leighl, Frances A. Shepherd	0
4	Effect of Immunosuppression in Risk of Developing Generalized Symptoms in Ocular Myasthenia Gravis 2024 ·Neurology ·Deepak Menon, (unknown), Hans Katzberg, Vera Bril, (unknown), Carolina Barnett	3
5	Whole‐body magnetic resonance neurography in patients with chronic inflammatory demyelinating polyneuropathy 2024 ·Muscle & Nerve ·Davood Fathi, Ali Naraghi, Lawrence M. White, (unknown), Carolina Barnett, Ari Breiner, Vera Bril, Hans Katzberg	2
6	Patient-reported preferences for subcutaneous or intravenous administration of parenteral drug treatments in adults with immune disorders: a systematic review and meta-analysis 2024 ·Journal of Comparative Effectiveness Research ·Vera Bril, Johannes Lampe, Nichola Cooper, Peter Kießling, Ann Gardulf	3
7	Rozanolixizumab responder and minimal symptom expression rates in generalized myasthenia gravis: Pooled phase 3 and extension studies 2023 ·Journal of the Neurological Sciences ·Vera Bril, John Vissing, Artur Drużdż, Julian Großkreutz, Ali A. Habib, Renato Mantegazza, Sabrina Sacconi, Kimiaki Utsugisawa, Tuan Vu, (unknown), Bernhard Greve, Franz Woltering, (unknown)	1
8	Clinical characteristics and treatment outcomes in patients with double‐seronegative myasthenia gravis 2023 ·European Journal of Neurology ·(unknown), Carolina Barnett, Mónica Alcántara, Vera Bril	9
9	Reliability of confocal corneal microscopy for measurement of dendritic cell density in suspected small fiber neuropathy 2023 ·Muscle & Nerve ·Juan Idiáquez, (unknown), Carolina Barnett, Bruce A. Perkins, Vera Bril	2
10	Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open‐label extension 2023 ·Annals of Clinical and Translational Neurology ·Richard J. Nowak, Ari Breiner, Vera Bril, Jeffrey A. Allen, Shaida Khan, Todd Levine, Daniel Jacobs, Gregory Sahagian, Zaeem A. Siddiqi, Jing Xu, William L. Macias, Michael Benatar, (unknown)	11
11	Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study 2023 ·European Journal of Neurology ·Mamatha Pasnoor, Vera Bril, Todd Levine, Jaya Trivedi, Nicholas J. Silvestri, Milind A. Phadnis, Hans Katzberg, David Saperstein, Gil I. Wolfe, Laura Herbelin, (unknown), Andrew Heim, Jeffrey Statland, Richard J. Barohn, Mazen M. Dimachkie	2
12	Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis 2023 ·Neurology ·Carlo Antozzi, Jeffrey T. Guptill, Vera Bril, Josep Gámez, Sven G. Meuth, Richard J. Nowak, Dianna Quan, Teresa Sevilla, Marie‐Hélène Jouvin, (unknown), Keith Karcher, Sindhu Ramchandren, (unknown), Leona Ling, (unknown), Santiago Arroyo, (unknown)	30
13	Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals 2022 ·Drugs ·Deepak Menon, Vera Bril	81
14	Thymoma pathology and myasthenia gravis outcomes 2021 ·Muscle & Nerve ·Deepak Menon, Hans Katzberg, Carolina Barnett, Prodipto Pal, Andrea Bezjak, Shaf Keshavjee, Vera Bril	14
15	Telephone consultation for myasthenia gravis care during the COVID‐19 pandemic: Assessment of a novel virtual myasthenia gravis index 2021 ·Muscle & Nerve ·Deepak Menon, (unknown), Carolina Barnett, Joy Vijayan, Hans Katzberg, Davood Fathi, Mónica Alcántara, Vera Bril	11
16	Practical Aspects of Transitioning from Intravenous to Subcutaneous Immunoglobulin Therapy in Neuromuscular Disorders 2021 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Deepak Menon, (unknown), Vera Bril	6
17	Clinical profile and impact of comorbidities in patients with very‐late‐onset myasthenia gravis 2021 ·Muscle & Nerve ·Joy Vijayan, Deepak Menon, Carolina Barnett, Hans Katzberg, Leif Erik Lovblom, Vera Bril	27
18	Nerve function varies with hemoglobin A1c in controls and type 2 diabetes 2017 ·Journal of Diabetes and its Complications ·Alon Abraham, Carolina Barnett, Hans Katzberg, Leif E. Lovblom, Bruce A. Perkins, Vera Bril	4
19	Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED] breakdown → 2011 ·Neurology ·Vera Bril, J. England, Gary M. Franklin, Miroslav Bačkonja, (unknown), David Del Toro, Eva L. Feldman, Donald Iverson, Bruce A. Perkins, James W. Russell, Douglas W. Zochodne	449
20	Symmetry of nerve conduction studies in different stages of diabetic polyneuropathy 2002 ·Muscle & Nerve ·Bruce A. Perkins, Madeline Ngo, Vera Bril	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact